Pulmonary infection due to Mycobacterium xenopi

Interactions between Mycobacterium xenopi, amoeba and human cells

Outbreaks due to Mycobacterium xenopi have been linked with contaminated water. M. xenopi has been shown to interact with the biofilm formed in water distribution systems and to be hosted by free-living Acanthamoeba. The present study investigated the interaction between M. xenopi and A. polyphaga amoeba, and between M. xenopi and human fibroblast HEL cells. Examination using the light microscopy together with electronic and confocal microscopy demonstrated that M. xenopi was located within the amoeba and in HEL cells. The Light Cycler measurement of the M. xenopi:A. polyphaga DNA ratio and the M. xenopi:HEL cell DNA ratio demonstrated intra-amoebal and intracellular growth of M. xenopi with doubling-times of five-days and 10 days, respectively. Intra-amoebal M. xenopi survived protozoan encystment and germination. These data demonstrate that M. xenopi is a facultative intra-amoebal and intracellular pathogen. Testing intra-amoebal M. xenopi might be necessary to properly evaluate decontamination procedures for hospital water supply systems in order to achieve eradication.

Mycobacterium xenopi pneumonia in the southeastern United States

Mycobacterium xenopi (M. xenopi) is a slow-growing, nontuberculous mycobacterium (NTM). This organism is found in fresh water and has been isolated in water samples collected from water systems in homes and hospitals. Before the acquired immunodeficiency syndrome epidemic, M. xenopi infection was infrequent and occurred in clusters; however, M. xenopi is now a recognized cause of pulmonary infection in immunocompetent patients with preexisting lung disease. The classic chest x-ray appearance is cavitary apical pulmonary disease, which mimics tuberculosis. M. xenopi is currently one of the most common NTM pathogens in parts of England and Canada and has been reported in parts of the northeastern United States. Whether the isolation of M. xenopi from our patient in Tennessee represents a new geographic distribution of this organism or technologic advancements that now allow for reliable identification is debatable. This case serves as a reminder to clinicians that the incidence of NTM infection is rising in the United States and that unusual NTM are capable of causing disease even in patients who are not immunocompromised.

In vitro sensitivity of Mycobacterium xenopi to five antibiotics

We tested 20 strains of Mycobacterium xenopi (M. xenopi) in order to evaluate their in vitro sensitivity to amikacine, clarithromycine, ethambutol, ofloxacine and rifampicin, by establishing minimal inhibitory concentration (MIC) on agar medium. MICs of amikacine, clarithromycine and ofloxacine are low, so that these antibiotics can be used in the treatment of M. xenopi infections. MICs of ethambutol are higher than seric concentrations. Though, its therapeutic use is due to its in vivo ability to enhance penetration of other antibiotics in mycobacteria. Strain sensitivity to rifampicin seems heterogeneous but the small number of tested strains does not entitle the exclusion of rifampicin from the treatment of M. xenopi infections.

Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo

In recent years, a number of newly identified species of the genus Mycobacterium (M.) have been isolated from tissues of both immunocompetent and immunocompromised patients, e.g. M. celatum, M. intermedium, M. interjectum, M. bohemicum, M. conspicuum, M. confluentis, M. heidelbergense, M. lentiflavum, and M. branderi. Little is known about their in vivo virulence characteristics and the host factors predisposing to infection with these strains. In an effort to elucidate the pathogenesis of these nontuberculous mycobacterial species, BALB/c and syngeneic IFNgamma-deficient (GKO) mice were intravenously infected with 106 colony forming units of each of these species, and bacterial growth in infected organs and the development of splenomegaly and granulomatous liver lesions were examined for a period of 3 months. Based on their in vivo virulence, mycobacterial strains could be divided into three major groups: (i) Most species examined either grew progressively or persisted at plateau levels in the livers and spleens of immunocompetent mice, and their growth was increased in GKO mice. (ii) M. heidelbergense, M. intermedium and another species not officially accorded separate taxonomical status were eliminated in BALB/c mice, but persisted in GKO mice. (iii) M. confluentis, M. lentiflavum and another novel species were eradicated even in the absence of IFNgamma. Nontuberculous mycobacterial species differed widely in their capacity to induce splenomegaly and lymphadenopathy in GKO mice. In conclusion, IFNgamma is a crucial determinant of infection outcome with most, but not all opportunistic mycobacterial species.

Mycobacterium xenopi pulmonary infection: evaluation with CT

PURPOSE

Our goal was to describe the CT appearances of Mycobacterium xenopi pulmonary infection.

METHOD

A retrospective study period of 75 months was used. Eight immunocompetent patients fulfilled the American Thoracic Society criteria for M. xenopi infection and had CT scans of the thorax. CT scans were reviewed by two observers, and decisions were reached by consensus.

RESULTS

Seven patients demonstrated upper lobe cavitary disease: one mass with cavity, one nodule with cavity, three consolidation with multiple cavities, and two cavities only. One patient demonstrated upper lobe consolidation only. All patients demonstrated adjacent lung architectural distortion indicating fibrosis and centrilobular nodules suggesting endobronchial spread of infection. Seven patients had a clinical history of preexisting chronic obstructive pulmonary disease that was confirmed by CT. Four patients demonstrated adjacent pleural disease.

CONCLUSION

M. xenopi pulmonary infection usually affects patients with preexisting pulmonary emphysema. It predominantly affects the upper lobes, usually with cavitary opacities and evidence of fibrosis and endobronchial spread of infection.